12:00 AM
 | 
Jan 01, 2007
 |  BioCentury  |  Finance

Follow-on performance

Follow-on performance

Follow-on performance
Follow-ons rallied in 2006 to raise $5.5 billion - second only to the $11.2 billion raised in 2000. The fourth quarter accounted for almost half this money, with a $1 billion financing by Celgene (CELG) making up a significant portion of the $2.6 billion in 4Q deals. There were six double-digit gainers post-deal compared to three double-digit losers, allowing the follow-on...

Read the full 326 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >